FDA authorizes emergency use for quicker, but less reliable coronavirus antigen test
With the United States struggling to meet the recommended quota of coronavirus tests per day, the Food and Drug Administration issued the first emergency use authorization Friday for a COVID-19 antigen test.
The test, produced by San Diego-based manufacturer Quidel, can diagnose COVID-19 by detecting fragments of protein found on or within the virus present in samples collected from the nasal cavity using swabs. The test produces results within minutes — much more quickly than many other tests on the market, which are more complex to conduct and analyze — but the technology is also more liable to result in false negatives, so an additional PCR test may be necessary to confirm.
But once production ramps up, so will the country's ability to test millions of Americans per day. Douglas Bryant, Quidel's chief executive, told The Wall Street Journal, they hope to have 200,000 tests available as soon as next week. Read more at CNBC and The Wall Street Journal.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Brodet (fish stew) recipe
The Week Recommends This hearty dish is best accompanied by a bowl of polenta
By The Week UK Published
-
Phone hacking: victory for Prince Harry?
Talking Point Even those who do not share the royal's views about the press should 'commend' his dedication to pursuing wrongdoing
By The Week UK Published
-
Donald Trump's grab for the Panama Canal
The Explainer The US has a big interest in the canal through which 40% of its container traffic passes
By The Week UK Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published